Reduced corticosteroid use in adult patients with primary immune thrombocytopenia receiving romiplostim.
about
Romiplostim: a review of its use in immune thrombocytopenia.Romiplostim for the treatment of primary immune thrombocytopenia.Bleeding and mortality outcomes in ITP clinical trials: a review of thrombopoietin mimetics data.Thrombopoietin receptor agonists in primary immune thrombocytopenia.Cost effectiveness of romiplostim for the treatment of chronic immune thrombocytopenia in IrelandLong-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials.Romiplostim as a treatment for immune thrombocytopenia: a review.Successful treatment of eltrombopag-resistant refractory immune thrombocytopenia with romiplostim.Initial romiplostim dosing and time to platelet response in patients with treatment refractory immune thrombocytopenia.Effect of thrombopoietin receptor agonists on leukocyte and haematopoietic stem and progenitor cells in the peripheral blood of patients with immune thrombocytopenic purpura.
P2860
Q33399598-C35F21FE-63B0-49DA-9742-CBBB2E9668BDQ33400560-92CDCDD4-F9B0-423E-90FA-A988462A7C21Q33401956-4456D4BC-D2C6-4760-896D-D4AD28C07499Q33407623-39C9B200-CBFD-427E-83DB-45CFB7629189Q33409109-32956F9E-5C8C-460B-97EE-F1F43A921655Q33409611-E4BDF111-6DC7-4FF5-BB66-08ADCEDB184DQ33420059-A055A2F6-934E-456F-9DA4-3D319F7A25B0Q45058551-2961CEF9-97CE-46AD-BB97-448B368C3F23Q47213468-1D5FC2C3-8E05-4AAA-A238-76F4DF203403Q47720114-6489DC47-1200-46C9-A1DC-207D7F018AB2
P2860
Reduced corticosteroid use in adult patients with primary immune thrombocytopenia receiving romiplostim.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Reduced corticosteroid use in ...... topenia receiving romiplostim.
@ast
Reduced corticosteroid use in ...... topenia receiving romiplostim.
@en
type
label
Reduced corticosteroid use in ...... topenia receiving romiplostim.
@ast
Reduced corticosteroid use in ...... topenia receiving romiplostim.
@en
prefLabel
Reduced corticosteroid use in ...... topenia receiving romiplostim.
@ast
Reduced corticosteroid use in ...... topenia receiving romiplostim.
@en
P2093
P2860
P1433
P1476
Reduced corticosteroid use in ...... topenia receiving romiplostim.
@en
P2093
Ann Janssens
Georg Kreuzbauer
Ingrid Pabinger-Fasching
Marc Michel
Peter A W te Boekhorst
P2860
P304
P356
10.1179/102453311X13025568942005
P577
2011-09-01T00:00:00Z